February 2026 Options Now Available For Kyndryl Holdings (KD)

Kyndryl (KD) is the subject of two option trade ideas: a $23 put trading with a $0.25 bid (implying a net cost basis of $22.75 if assigned) and a $28 call trading with a $0.05 bid for use in a covered-call. The $23 put is ~16% out-of-the-money with a 76% probability of expiring worthless and a YieldBoost of 1.09% (6.20% annualized); the $28 covered call is ~2% OTM with a 49% probability of expiring worthless and a 0.18% YieldBoost (1.04% annualized). Implied volatilities are 81% for the put and 48% for the call versus a trailing 12-month volatility of 45%, highlighting asymmetric option pricing and potential income-generation versus capped upside risk.

Analysis

Market structure: The option chain on KD shows asymmetric demand—puts IV 81% vs realized 45%—which benefits option sellers collecting elevated premiums and specialist desks providing liquidity, while hurting directional buyers and holders who face higher hedging costs. The put skew implies market participants are paying up for downside protection (16% OTM $23 strike) which signals higher perceived idiosyncratic tail risk for KD than for the sector; expect persistent bid for downside protection until a catalyst resolves uncertainty.

Risk assessment: Near-term (days–weeks) risk is event-driven: an earnings miss, major contract loss, or client churn can reprice KD >20% lower and validate the high put IV; medium-term (months) the key risks are revenue/contract cadence and macro IT spend cuts. Hidden dependencies include low option liquidity, assignment timing (cash requirements if assigned), and broker-driven gamma hedging that can exacerbate short-term moves; a volatility spike >120% would materially widen spreads and blow up naked sellers.

Trade implications: Tactical: implement cash-secured put selling on KD using defined-risk verticals (sell $23 Feb 2026 put / buy $20 put) sized 1–3% portfolio to target owning KD at ~$22.75 breakeven while capping downside. Avoid buying shares to sell $28 covered calls – the 0.18% yield is poor; prefer short-dated put sales to harvest elevated put premium or buy protection if you’re long KD (long puts or collars).

Contrarian angle: Consensus accepts put premium as fair insurance but the 36-point IV skew (81 vs 45) looks overstated relative to realized vol; if no adverse catalyst in 60–90 days, expect IV contraction and positive carry for sellers. Historical spin-offs often mean-revert volatility once contracts/clients stabilize; the mispricing window is 1–3 months and can be exploited with disciplined defined-risk shorts.

Key Decisions for Investors

• Establish a cash-secured, defined-risk put spread on KD: sell Feb-2026 $23 put and buy Feb-2026 $20 put sized to 1–3% of portfolio to target effective entry ≈ $22.75 and cap max loss to ~$3 minus net credit; close or roll if KD < $21 or IV >120%.
• Avoid entering a buy-and-write (buy KD at $27.44 and sell $28 Feb-2026 call): instead, if you want equity exposure, buy KD and collar it (sell nearer-term calls, buy longer-dated puts) because naked covered-call yield (0.18%) is immaterial versus downside risk.
• If contrarian and short-term volatility seller: sell near-dated puts (30–90 days) only if bid remains ≥$0.20 and skew (put IV – call IV) stays >30 points; size to 0.5–1.5% and take profits if IV compresses by ≥20 vol points or premium decays by 50%.
• If risk-off view: buy Feb-2026 $23 puts or protective puts into existing KD longs if you expect a >15% downside in next 2–3 months; allocate no more than 0.5% notional to avoid paying inflated IV unless a catalyst is imminent.